MetLife Investment Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-38,018
| Closed | -$470K | – | 2846 |
|
|
2024
Q4 | $470K | Buy |
38,018
+2,767
| +8% | +$31.7K | ﹤0.01% | 1834 |
|
|
2024
Q3 | $401K | Buy |
35,251
+372
| +1% | +$3.73K | ﹤0.01% | 1899 |
|
|
2024
Q2 | $249K | Buy |
34,879
+9,444
| +37% | +$72.2K | ﹤0.01% | 2113 |
|
|
2024
Q1 | $170K | Sell |
25,435
-6,738
| -21% | -$46.4K | ﹤0.01% | 2282 |
|
|
2023
Q4 | $209K | Hold |
32,173
| – | – | ﹤0.01% | 2221 |
|
|
2023
Q3 | $304K | Hold |
32,173
| – | – | ﹤0.01% | 1946 |
|
|
2023
Q2 | $449K | Hold |
32,173
| – | – | ﹤0.01% | 1767 |
|
|
2023
Q1 | $604K | Hold |
32,173
| – | – | ﹤0.01% | 1523 |
|
|
2022
Q4 | $443K | Hold |
32,173
| – | – | ﹤0.01% | 1716 |
|
|
2022
Q3 | $615K | Sell |
32,173
-3,421
| -10% | -$62.3K | 0.01% | 1482 |
|
|
2022
Q2 | $543K | Hold |
35,594
| – | – | ﹤0.01% | 1592 |
|
|
2022
Q1 | $725K | Buy |
35,594
+11,881
| +50% | +$242K | ﹤0.01% | 1539 |
|
|
2021
Q4 | $692K | Hold |
23,713
| – | – | 0.01% | 1315 |
|
|
2021
Q3 | $511K | Hold |
23,713
| – | – | ﹤0.01% | 1507 |
|
|
2021
Q2 | $608K | Hold |
23,713
| – | – | 0.01% | 1452 |
|
|
2021
Q1 | $432K | Buy |
23,713
+7,910
| +50% | +$131K | ﹤0.01% | 1613 |
|
|
2020
Q4 | $182K | Sell |
15,803
-3,700
| -19% | -$33.8K | ﹤0.01% | 2030 |
|
|
2020
Q3 | $149K | Sell |
19,503
-11,359
| -37% | -$86K | ﹤0.01% | 2028 |
|
|
2020
Q2 | $203K | Hold |
30,862
| – | – | ﹤0.01% | 1895 |
|
|
2020
Q1 | $158K | Hold |
30,862
| – | – | ﹤0.01% | 1823 |
|
|
2019
Q4 | $237K | Hold |
30,862
| – | – | ﹤0.01% | 1888 |
|
|
2019
Q3 | $164K | Hold |
30,862
| – | – | ﹤0.01% | 2058 |
|
|
2019
Q2 | $173K | Buy |
+30,862
| New | +$127K | ﹤0.01% | 2115 |
|
|
2019
Q1 | – | Sell |
-26,181
| Closed | -$107K | – | 2595 |
|
|
2018
Q4 | $107K | Hold |
26,181
| – | – | ﹤0.01% | 2273 |
|
|
2018
Q3 | $180K | Buy |
+26,181
| New | +$155K | ﹤0.01% | 2144 |
|
Other funds holding CDMO
MetLife Investment Management's CDMO Position: Q1 2025 in Review
MetLife Investment Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 38,018 shares — an estimated $470K sold.
MetLife Investment Management first reported a position in CDMO in Q3 2018 and held it in 25 quarters. The position peaked at $725K in Q1 2022. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- MetLife Investment Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- MetLife Investment Management sold 38,018 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $470K.
- MetLife Investment Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 25 quarters.
- MetLife Investment Management's Avid Bioservices, Inc. Common Stock position peaked at $725K in Q1 2022.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on MetLife Investment Management's 13F filing for Q1 2025, filed 14 May 2025.